The toothpaste
Question

What happens if you miss a week of a potassium nitrate toothpaste?

Nobody has measured a week, but the week is bracketed at both ends, and neither end looks like a reset. Two manufacturer-funded double-blind randomised trials have taken people off a potassium nitrate paste on purpose — one for a single day, one for three weeks — and in both the ground held for longer than the pack instructions imply, while the Cochrane review that pooled this ingredient only ever read its trials at six to eight weeks of unbroken brushing127. S3 Sensitivity Science™ is built as a daily toothpaste rather than a fortnight's treatment, which is a fact about the product rather than a result.

What was checked14 peer-reviewed studies, product information as published by each brand, and Oral Health Foundation and NHS guidance

Key points
  • No published trial has tested a week away from a potassium nitrate toothpaste; the trials in this field take their readings while everybody is still brushing, and the Cochrane pooling of six of them sits at six to eight weeks7.
  • In the one manufacturer-funded double-blind randomised trial that stopped the paste and measured, three weeks with none of the active cost the potassium nitrate group roughly a seventh of the ground it had gained — a decline slow enough that the proposed mechanism, called unconfirmed in an intact human tooth by a narrative review of 27 clinical trials, gives no way to explain it26.
  • A second manufacturer-funded double-blind randomised trial built a deliberate day off into its schedule, and the readings taken twenty-four hours later were no worse; its placebo arm drifted the same way over the same day, the sort of movement a network meta-analysis of thirty randomised trials measured right across this literature18.
  • Potassium nitrate appears only in the long-term group of a systematic review of 74 randomised trials that grouped treatments by when their effect reached significance, so whatever a break costs is rebuilt over weeks and not over days5.
  • S3 is built as a daily toothpaste rather than a course of treatment, so the routine it asks for is the one you already have.

What does a week off actually cost?

Less than the story you have been telling yourself, and nobody can give you the figure for a week itself.

Start with the shorter side. In a double-blind randomised trial of 127 adults published in 2026, whose authors are employees of the Lion Corporation that makes the pastes on test or hold research grants from it, everybody moved onto the placebo paste for one day after the four-week visit and came back a day later to be measured1. In the arm using 5% potassium nitrate on its own, the tables that manufacturer published record a probe threshold of 22.88 g at four weeks and 24.63 g the following day, and a cold-air score of 1.75 then 1.58 — both marginally better after the day off, not worse1. The authors describe the exercise as a test of whether the effect persists through a temporary stop. One thing has to be said in the same breath: in the same manufacturer-funded trial the placebo arm's readings moved in the same direction over the same twenty-four hours, so some of what looks like persistence is the measurement settling rather than the paste holding on1.

Now the longer side. A double-blind randomised trial of 120 adults, funded by Procter & Gamble with seven of its eight authors on the company payroll, ran a marketed potassium nitrate paste against a plain fluoride control for eight weeks and then put every group on that plain control for three weeks more2. Read the potassium nitrate column of the tables that manufacturer published: on the cold-air (Schiff) scale the group averaged 2.46 when it started, 1.24 at week eight with the paste in daily use, and 1.40 at week eleven after three weeks with none of the active anywhere near its teeth2. Set those three figures beside each other and the shape is obvious. Of the distance that group travelled in eight weeks, three weeks of nothing gave back roughly a seventh of it, and in the manufacturer's own analysis it was still significantly ahead of the control at week eleven2.

A week sits inside that bracket, and no published trial has looked at it. Five PubMed searches run for this page on the tenth of September 2026 — for cessation, discontinuation, washout, relapse, interrupted, intermittent, treatment holidays and stop-start use of potassium toothpastes — returned between four and fifty-nine records each, and none of them was about a person taking a break. The only regimen trial of any kind used a different active: a manufacturer-funded examiner-blind randomised trial of 76 adults gave a bioactive-glass paste either continuously for 24 weeks or in two eight-week courses separated by eight weeks on an ordinary fluoride paste, and the two schedules ended level, with small improvements on cold air and none on the probe test either way3. Eight weeks off cost those users nothing that could be measured. It was not potassium, and this page will not pretend that it was.

What was stopped, and for how longStudy, design and sizeFunding, as declaredWhat happened
A 5% potassium nitrate paste, for one day after four weeks of useIshii 2026, double-blind randomised trial, 127 adultsFunded by Lion Corporation; its authors are employees of the company or hold its grants1Probe threshold 22.88 g then 24.63 g, cold-air score 1.75 then 1.58 — nothing measurable lost, but the placebo arm drifted the same way
A marketed potassium nitrate paste, for three weeks after eight weeks of useBiesbrock 2025, double-blind randomised trial, 120 adultsFunded by Procter & Gamble; seven of the eight authors are employees of the company2Cold-air score 1.24 at week eight and 1.40 at week eleven, against 2.46 at baseline; still significantly ahead of the control group
A bioactive-glass paste, for eight weeks between two eight-week coursesMason 2017, examiner-blind randomised trial, 76 adultsFunded by GSK Consumer Healthcare; the first author is an employee of the company3The interrupted and the continuous schedules finished level on every outcome; the improvements were small either way
A potassium nitrate paste, for one weekNobody has run itGuidance, not measurement: the Oral Health Foundation says you need to keep using these toothpastes to maintain the effect4
A potassium nitrate paste, repeatedly, by someone who keeps stopping and restartingNobody has run itBrand statement, not measurement: Sensodyne says that if you stop brushing with it, your sensitivity can return
S3's own combination of potassium nitrate, hydroxyapatite and fluoride, for any length of timeNobody has run itNot measured. No trial has stopped this formula and read what survived

The empty cells are the point of the table. Read down the funding column too: every measurement anybody has of what stopping does was funded by a company that sells toothpaste123, and a break that costs less than the pack implies is not the finding a marketing department would have paid for.

Why does it take weeks to build back?

Because it took weeks to build in the first place, and the timing is one of the better-established things about this ingredient.

A systematic review of 74 randomised trials, covering 5,366 patients, grouped every desensitising treatment by the follow-up window in which its reduction reached significance: immediate, up to a month, and longer5. Potassium nitrate appears in the long-term group and nowhere earlier; no toothpaste of any kind reached significance inside seven days, and the treatments that did were the ones a dentist applies in a surgery5. The manufacturer-funded eight-week trial fills in the middle of that picture — the potassium arm had separated from the control on cold air by day three but not on the probe test, where it needed a fortnight2.

So relief that builds over weeks is how the active works rather than a sign that it is failing, and a week off is a week's setback rather than a return to the beginning. The sibling page on how long to give a new tube before judging it works through the first fortnight in more detail.

If it leaves nothing behind, why does a break cost so little?

That is the honest puzzle at the centre of this page, and it has no published answer.

The working model for potassium salts is that ions from the paste raise the potassium concentration around the nerve endings inside the dentine and make them slower to fire. A narrative review of 27 clinical trials, sixteen of them double-blind trials of potassium toothpastes, reports that all sixteen found significant reductions and states plainly that this mechanism has never been confirmed in an intact human tooth6. Nothing about it predicts a residue. An ion gradient with no source should wash out in hours, not hold most of its ground across three weeks.

The occlusion evidence does not rescue the story either, and it disagrees with itself. In a four-week double-blind randomised trial of 30 adults, the companion electron-microscope work found that a 5% potassium nitrate paste had closed no tubules at all, while the comparator paste had9. An in vitro electron-microscope study of 90 dentine samples cut from 45 extracted premolars found the opposite: detectable occlusion from a potassium nitrate toothpaste by day fourteen, more with twice-daily application than once10. Two bench protocols, two answers, and the authors of the second say themselves that randomised trials would be needed to show anything in a person10. This page does not resolve that, and neither should a tube.

Two consequences follow, and the second is uncomfortable. First, if you feel worse after a week off, the mechanism gives no reason to expect that you have lost everything, because the one measurement of a longer gap says otherwise. Second, some of what any of us feel is the response to being treated: a network meta-analysis of 30 randomised trials measured a significant placebo effect across this literature and found potassium toothpastes not significantly different from placebo within its own network8, and the Cochrane review of six trials found the effect on air-blast and probe testing significant while what patients said about their own sensitivity was not7. That contradictory pair — a Cochrane review whose authors concluded there was no clear evidence for these toothpastes, and a network in which potassium did not separate from placebo — is the evidence base under the nerve active S3 uses, and this page prints it rather than filing it away78.

Which habits actually change this, and which are folklore?

One of them has guidance behind it, one has a mixed pooled literature, and one has nothing at all.

Continued use is the one with guidance. The Oral Health Foundation, on a page carrying an educational grant from a toothbrush manufacturer, names potassium citrate, potassium nitrate and stannous fluoride as the ingredients to look for and says you need to keep using these toothpastes to maintain the effect4. That is advice written for a population, not a measurement of what a break costs, and the two are not in conflict: keep going is sensible advice even when the one measurement anybody has taken turned out to be forgiving. The market leader says the same thing about its own tube: asked on its FAQ page whether teeth become sensitive again after stopping, Sensodyne answers that "if you stop brushing with Sensodyne toothpaste, your sensitivity can return, so it is best to make Sensodyne your daily toothpaste". That is what the brand says about its own product, set beside the readings above, and this page does not adjudicate between the two.

A desensitising mouthwash has pooled evidence, and it points two ways. A meta-analysis of nine randomised trials found potassium-salt mouthwashes beat control on probe testing from two weeks and on the cold-air test from four11. A meta-analysis of seven randomised placebo-controlled trials found the mirror image: a significant improvement in what patients reported about their own pain at eight weeks and nothing significant on the probe or thermal tests12. Added to a fluoride toothpaste in an examiner-blind randomised trial of 135 adults funded by GSK Consumer Healthcare, with the manufacturer's employees among the authors, a 3% potassium nitrate rinse beat the toothpaste alone on the cold-air test at four weeks and not at eight13. Worth trying, on that record, and not worth expecting much from.

Rinsing after brushing is the folklore, and an earlier draft of this page was part of the problem: it called rinsing "the quiet culprit" for potassium nitrate and cited nothing for it, because there is nothing to cite. Searches for potassium retention, substantivity or clearance after brushing returned eight records, none of them about a potassium toothpaste and a rinse; the retention work they surfaced is about fluoride. The Oral Health Foundation does tell you to spit and not rinse4, and that advice stands on its own authority. What nobody has shown is that rinsing removes potassium from a tooth, and this page withdraws the claim rather than dressing it up.

How do you break the cycle, and what does a daily formula like S3 change about it?

By treating the tube as a daily toothpaste instead of a course of treatment, which is a change of framing and not of effort.

Three things follow from the evidence above. Keep one tube in use instead of rotating between two. Nearly every measurement in this field was taken on a single paste used without a break, and the one manufacturer-funded experiment that deliberately interrupted a regimen ran on a bioactive glass, not on potassium3. Judge the result over weeks against something written down rather than against memory. The longest look anyone has taken at self-managed use is an open-label clinical study of 655 adults who brushed with a 5% potassium nitrate toothpaste for 24 weeks in their own homes, funded by Haleon with five of its seven authors employed there, and what it recorded was a monthly questionnaire; it had no control group at all, so it cannot tell you the paste caused what it recorded14. And expect nobody to have set this up for you: in a qualitative interview study of 18 Australian adults with confirmed dentine hypersensitivity, supported by the same manufacturer, 89% were using a desensitising toothpaste and every one of them had chosen it alone, with none proactively screened for the condition by a dentist15.

What an everyday toothpaste changes is not the pharmacology but the friction: it is easier to keep using something that is already your toothpaste. S3 pairs its nerve-calming active with two forms of hydroxyapatite and full adult-strength fluoride in one tube, so it does the ordinary job of a toothpaste as well as the sensitivity one, and it is designed for twice-daily use as a complete daily toothpaste rather than a short treatment. That says what the formula contains, not how well it survives a break: nobody has stopped this combination and read what was left, and this page will not imply that it holds up where others do not.

When is the break not the explanation?

When the pain has changed shape rather than simply come back.

A potassium nitrate paste was made for a short, sharp response to cold, sweetness or air that stops when the trigger does. An ache that outlasts the drink, pain on biting, pain that wakes you, or pain that has narrowed to one tooth is a different complaint and no tube addresses it. The Oral Health Foundation asks you to see a dentist when the pain is severe, when sensitivity has run on past a few weeks, when only one tooth is involved or when it arrived suddenly, and names decay, a cracked tooth, gum problems and infection behind those signs4. The NHS sets its own threshold at toothache lasting more than two days, or toothache that painkillers do not settle, or toothache arriving with a high temperature, pain on biting, red gums, a bad taste or a swollen cheek or jaw16. Take the tube to the appointment; what you need next is a diagnosis. The sibling pages on sensitivity that keeps deteriorating and on why a paste seems to have stopped working take those cases on their own terms, and the Journal covers the routine from the other end in how sensitive toothpastes work and why yours might not be working.

This page compares ingredients and stated actions only, not clinical performance, based on what each brand states about its own formula. Prices and formulations may change; always check the pack.

Frequently asked questions

If I miss a week of S3, do I start from zero?

Almost certainly not. What was measured, in a manufacturer-funded double-blind randomised trial, is a group whose cold-air score sat at 1.24 after eight weeks of daily use and 1.40 three weeks after switching to a plain paste, against 2.46 before any of it started2. On the shorter side, a day off in a second manufacturer-funded double-blind trial cost nothing that showed up in the numbers1. Neither of those manufacturer-funded trials used S3, or any paste carrying potassium nitrate and hydroxyapatite together12. Treat a missed week as ground to make up rather than a fresh start, and give the tube weeks rather than days to do it5.

Does rinsing after brushing cancel it out?

No study has ever tested that for potassium. Searches for potassium retention or clearance after brushing return work on fluoride and nothing on this question, so anyone who tells you that a rinse washes the active off a tooth is reasoning, not reporting. Spitting without rinsing is still what the Oral Health Foundation asks for, and following it costs nothing4.

Is a desensitising mouthwash worth adding while I get back into the routine?

It has pooled randomised evidence, and the two syntheses disagree about what moves. One meta-analysis of nine trials found potassium-salt rinses ahead of control on probe testing from two weeks and on cold air from four11; another, of seven placebo-controlled trials, found the benefit only in what patients said about their own pain at eight weeks12. In a GSK-funded examiner-blind randomised trial of 135 adults, with the manufacturer's employees among its authors, adding a 3% rinse to a fluoride toothpaste separated from the toothpaste alone on one measure at one visit13. That is a reasonable thing to try and a poor thing to rely on.

Can you build up a tolerance, so that it stops working while you are still using it?

Nobody knows, because the question has never been put to a trial, and saying so is more useful than a guess. Potassium toothpastes are measured for eight weeks, or twelve at the outside, and then the measuring stops7, which is far too short a run to see a fade even if one were there. What the eight-week readings show is the opposite shape: in the manufacturer-funded trial with the washout arm, the potassium nitrate benefit was larger at week eight than at week four2.

Where S3 sits

S3 is not a fortnight's treatment to be started and stopped: unlike a single-active sensitivity paste, it is the toothpaste you use every day. Its actives are meant to accumulate, which is why the window for judging S3 is two to four weeks and not the first brush. Over 20 practising UK dentists have put their own money into S3, and nine founding dentists advise on the formulation.

S3 Sensitivity Science™ pairs potassium nitrate with two hydroxyapatites and adult-strength fluoride in one daily paste.

See the toothpaste

S3 combines a nerve-calming active (5% potassium nitrate) with two forms of hydroxyapatite (10% nano-hydroxyapatite and 5% biomimetic hydroxyapatite, both as solution) and full adult-strength fluoride, in one daily toothpaste. Calm, strengthen, protect: the three actions sensitive teeth need, in one daily toothpaste. The formula is patent-pending S3 Repair Technology™, UK application GB2604755.5. Read more about S3.

References 16 sources

1
Ishii K, Suzuki T, Akabane C, Iizumi G, Suzuki N, Fukuda Y, Suzuki K, Kawaguchi N, Zhu R, Li D, Zhou Z, Hu D. Toothpastes containing potassium nitrate alone versus potassium nitrate combined with aluminum lactate in reducing dentin hypersensitivity: a randomized controlled trial. BDJ Open. 2026;12(1). doi:10.1038/s41405-026-00452-x Double-blind randomised controlled trial, 127 adults, eight weeks with a one-day discontinuation reading; funded by Lion Corporation.
2
Biesbrock AR, He T, Zou Y, Grender JM, Amini P, Sagel PA, Groth A, Klukowska M. Randomized clinical trial evaluating kinetic benefits of desensitizing agents: magnitude, onset, and stability of relief. Journal of Periodontology. 2025;96(12):1339-1351. doi:10.1002/JPER.24-0688 Double-blind randomised controlled trial, 120 adults, eight weeks of use plus a three-week washout; funded by Procter & Gamble.
3
Mason S, Kingston R, Shneyer L, Harding M. Clinical study to monitor dentinal hypersensitivity with episodic use of a desensitising dentifrice. BDJ Open. 2017;3:17011. doi:10.1038/bdjopen.2017.11 Examiner-blind randomised controlled trial, 76 adults, 24 weeks; funded by GSK Consumer Healthcare.
4
Oral Health Foundation. Sensitive teeth. https://www.dentalhealth.org/sensitive-teeth Accessed 2026-09-10.
5
Marto CM, Baptista Paula A, Nunes T, Pimenta M, Abrantes AM, Pires AS, Laranjo M, Coelho A, Donato H, Botelho MF, Marques Ferreira M, Carrilho E. Evaluation of the efficacy of dentin hypersensitivity treatments: a systematic review and follow-up analysis. Journal of Oral Rehabilitation. 2019;46(10):952-990. doi:10.1111/joor.12842 Systematic review, 74 randomised trials, 5,366 patients.
6
Orchardson R, Gillam DG. The efficacy of potassium salts as agents for treating dentin hypersensitivity. Journal of Orofacial Pain. 2000;14(1):9-19. Narrative review of 27 clinical trials, sixteen of them double-blind randomised trials of potassium toothpastes.
7
Poulsen S, Errboe M, Lescay Mevil Y, Glenny AM. Potassium containing toothpastes for dentine hypersensitivity. Cochrane Database of Systematic Reviews. 2006;2006(3):CD001476. doi:10.1002/14651858.CD001476.pub2 Cochrane systematic review and meta-analysis, six randomised trials, outcomes at six to eight weeks.
8
Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM. Network meta-analysis on the effect of desensitizing toothpastes on dentine hypersensitivity. Journal of Dentistry. 2019;88:103170. doi:10.1016/j.jdent.2019.07.008 Systematic review and network meta-analysis, 30 randomised trials.
9
Salian S, Thakur S, Kulkarni S, LaTorre G. A randomized controlled clinical study evaluating the efficacy of two desensitizing dentifrices. The Journal of Clinical Dentistry. 2010;21(3):82-87. Double-blind randomised controlled trial, 30 adults, with a companion electron-microscope test.
10
James JM, Puranik MP, Sowmya KR. Dentinal tubule occluding effect of potassium nitrate in varied forms, frequencies and duration: an in vitro SEM analysis. Journal of Clinical and Diagnostic Research. 2017;11(10):ZC08-ZC12. doi:10.7860/JCDR/2017/26442.10340 In vitro electron-microscope study, 90 dentine samples from 45 extracted premolars.
11
da Silva A, Deschamps Muniz RP, Almeida Lago MC, da Silva Junior EP, Braz R. Clinical efficacy of mouthwashes with potassium salts in the treatment of dentinal hypersensitivity: a systematic review and meta-analysis. Operative Dentistry. 2023;48(2):E31-E43. doi:10.2341/21-181-LIT Systematic review and meta-analysis, nine randomised trials.
12
Molina A, Garcia-Gargallo M, Montero E, Tobias A, Sanz M, Martin C. Clinical efficacy of desensitizing mouthwashes for the control of dentin hypersensitivity and root sensitivity: a systematic review and meta-analysis. International Journal of Dental Hygiene. 2017;15(2):84-94. doi:10.1111/idh.12250 Systematic review and meta-analysis, seven randomised placebo-controlled trials.
13
Hall C, Sufi F, Constantin P. Efficacy of an experimental 3% potassium nitrate mouthwash in providing long-term relief from dentin hypersensitivity: an 8-week randomized controlled study (Study 2). American Journal of Dentistry. 2017;30(3):156-160. Examiner-blind randomised controlled trial, 135 adults; funded by GSK Consumer Healthcare.
14
Grimaldi R, Baker SR, Shah P, Sanchez E, Shanga G, Gomez-Pereira PR, Parkinson CR. A real-world evidence study evaluating oral-health-related quality of life following the use of anti-sensitivity toothpaste for self-reported dentine hypersensitivity management. Journal of Clinical Periodontology. 2025;52(7):940-948. doi:10.1111/jcpe.14155 Prospective open-label clinical study with no control group, 655 enrolled and 577 analysed, 24 weeks; funded by Haleon.
15
Torwane N, Schuch HS, Dhanapriyanka M, Do L, Ha D. Why does dentine hypersensitivity remain undertreated despite being common and manageable? A qualitative study of patient experience and system-level barriers in Australia. Journal of Dentistry. 2026. doi:10.1016/j.jdent.2026.106989 Qualitative interview study, non-randomised, 18 adults; research programme supported by Haleon Australia.
16
NHS. Toothache. https://www.nhs.uk/symptoms/toothache/ Accessed 2026-09-10.